![](/rp/kFAqShRrnkQMbH6NYLBYoJ3lq9s.png)
Emma Walmsley - Wikipedia
Dame Emma Natasha Walmsley DBE (born June 1969) is the chief executive officer (CEO) of GSK plc. [1] She succeeded Sir Andrew Witty, who retired in March 2017. [2] Before GSK, she worked for L'Oréal for 17 years, and was a non-executive director of Diageo until September 2016. [3] She grew up in Barrow-in-Furness, Cumbria, England.
Board of directors and leadership team - GSK
Our board of directors is responsible for corporate governance and is ultimately accountable for the group's activities, strategy, risk management and financial performance. Our Chief Executive Officer is responsible for the management of the business …
Dame Emma Walmsley - GSK
Emma joined the Board as CEO Designate on 1 January 2017 and became CEO on 1 April 2017. She has been a member of the GSK Leadership Team since 2011, as the President and then CEO of GSK Consumer Healthcare.
Emma Walmsley - Forbes
Walmsley became CEO of GlaxoSmithKline in April of 2017, making her the first woman to run a major pharmaceutical company. In 2023, the U.S. FDA approved Arexvy, GSK's RSV vaccine, for use in the...
Emma Walmsley - CEO - GSK | LinkedIn
CEO, GSK · Proud to be leading GSK as we unite science, technology and talent to get ahead of disease together. We have big ambitions at GSK, to positively impact the lives of more than 2.5...
- Title: CEO, GSK
- Location: GSK
Emma Walmsley - Stories
Emma Walmsley has been GSK plc chief executive officer and a member of its board of directors since April 2017. Walmsley has been a member of GSK’s leadership team since 2011, originally as the president and then CEO of GSK Consumer Healthcare.
How GSK CEO Emma Walmsley kept her job and turned a
May 21, 2024 · When Elliott Investment Management came calling for the ouster of Emma Walmsley, the chief executive officer of GSK Plc found her remedy in a product almost 60 years in the making.
Emma Walmsley - Fortune
Emma Walmsley, CEO of GSK, is nearly eight years into her effort to return the British pharma company to growth, and her work is starting to pay off. Much credit goes to Arexvy, GSK’s...
GSK boosts CEO Emma Walmsley's pay to £12.7M after strong year
Mar 5, 2024 · With the fortunes of GSK on the rise after much tumult early in the decade, the company has rewarded CEO Emma Walmsley with a significant pay boost. Walmsley collected 12.7 million pounds...
Prescription for success: Emma Walmsley leads GSK ... - European CEO
In her first year as CEO, Emma Walmsley sold off GSK’s rare disease unit and began a strategic review of its cephalosporins antibiotic business. Living in Shanghai as the head of L’Oréal’s Chinese consumer business, Emma Walmsley was content.